TAUOPATHIES

Clinical trials for TAUOPATHIES explained in plain language.

Never miss a new study

Get alerted when new TAUOPATHIES trials appear

Sign up with your email to follow new studies for TAUOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet finished but already full! 1 Completed 2 Terminated 1

Could a new drug slow Alzheimer's? large trial underway

Disease control Ongoing

This phase 3 study tests whether donanemab, an antibody given through an IV, can safely slow cognitive decline in 1500 people with early Alzheimer's. Participants receive either the drug or a placebo for up to 93 weeks. The main goal is to measure changes in thinking and daily fu…

Matched conditions: TAUOPATHIES

Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC

TAUOPATHIES

Get alerted when new TAUOPATHIES trials appear

Could a new drug slow Alzheimer's? large trial underway